Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii

被引:112
作者
Héritier, C [1 ]
Poirel, L [1 ]
Aubert, D [1 ]
Nordmann, P [1 ]
机构
[1] Hop Bicetre, Serv Bacteriol Virol, Assistance Publ Hop Paris, Fac Med Paris Sud, F-94275 Le Kremlin Bicetre, France
关键词
D O I
10.1128/AAC.47.1.268-273.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Clinical isolate Acinetobacter baumannii CLA-1 was resistant to a series of antibiotic molecules, including carbapenems. Cloning and expression of the beta-lactamase gene content of this isolate in Escherichia coli DH10B identified a chromosome-encoded oxacillinase, OXA-40, that differed by one or two amino acid changes from OXA-24, -25, and -26 and an AmpC-type cephalosporinase. The OXA-40 P-lactamase had a mainly narrow-spectrum hydrolytic profile, but it included ceftazidime and imipenem. Its activity was resistant to inhibition by clavulanic acid, tazobactam, sulbactam, and, like most of the other carbapenem-hydrolyzing oxacillinases, NaCl. OXA-40 had an FGN triad replacing a YGN motif at class D beta-lactamase (DBL) positions 144 to 146. Site-directed DNA mutagenesis leading to a Phe-to-Tyr change at DBL position 144 in OXA-40 gave a mutant enzyme with increased hydrolytic activity against most beta-lactams, including imipenem. Conversely, with a gene encoding the narrow-spectrum oxacillinase OXA-1 as the template, a nucleotide substitution leading to a Tyr-to-Phe change in the YGN motif of OXA-1 gave a mutant enzyme with decreased hydrolytic activity without an increase in carbapenem-hydrolyzing activity. Thus, the Phe residue in the FGN motif was not associated with carbapenem-hydrolyzing activity by itself but instead was associated with weak overall hydrolytic activity. Finally, this Phe residue in OXA-40 explained resistance to inhibition by NaCl whereas a Tyr residue in motif YGN was related to susceptibility to NaCl.
引用
收藏
页码:268 / 273
页数:6
相关论文
共 31 条
[1]   Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina [J].
Afzal-Shah, M ;
Villar, HE ;
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) :127-131
[2]   Worldwide emergence of carbapenem-resistant Acinetobacter spp. [J].
Afzal-Shah, M ;
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (05) :576-577
[3]   Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii [J].
Afzal-Shah, M ;
Woodford, N ;
Livermore, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :583-588
[4]  
[Anonymous], 1983, COLD SPRING HARBOR L
[5]   Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa [J].
Aubert, D ;
Poirel, L ;
Chevalier, J ;
Leotard, S ;
Pages, JM ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1615-1620
[6]   Molecular diagnosis of car scratch disease: A two-step approach [J].
Avidor, B ;
Kletter, Y ;
Abulafia, S ;
Golan, Y ;
Ephros, M ;
Giladi, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (08) :1924-1930
[7]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[8]   Chromosome-encoded class D β-lactamase OXA-23 in Proteus mirabilis [J].
Bonnet, R ;
Marchandin, H ;
Chanal, C ;
Sirot, D ;
Labia, R ;
De Champs, C ;
Jumas-Bilak, E ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :2004-2006
[9]   OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain [J].
Bou, G ;
Oliver, A ;
Martínez-Beltran, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1556-1561
[10]   Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii [J].
Bou, G ;
Martínez-Beltrán, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :428-432